Latisa Carson, MD
Obstetrics & Gynecology · Chula Vista, CANPI 1245229129
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $8,050 of the $10,445 with a category attached, or 77.1%. AbbVie accounts for 90.1% of it on its own, with 14 other manufacturers making up the rest. Reporting peaked in 2019 at $5,954 and has fallen 92.5% since, to $445 in 2025. Among obstetrics & gynecology clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 103 payments — averaging $101.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$9K
- Pfizer$244
- Astellas Pharma US Inc$181
- Intuitive Surgical$180
- Exeltis, USA Inc.$105
- Aspira Women's Health Inc$56
- plus $265 from 9 others
What the payments were for
- Speaking & faculty fees$8,05077%
- Travel & lodging$741%
- Food & beverage$2,22221%
- Education$991%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 62 | $9,415 |
| Pfizer | 16 | $244 |
| Astellas Pharma US Inc | 4 | $181 |
| Intuitive Surgical | 3 | $180 |
| Exeltis, USA Inc. | 5 | $105 |
| Aspira Women's Health Inc | 3 | $56 |
| Hologic Sales And Service, LLC | 2 | $56 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $52 |
| Stryker | 1 | $47 |
| Organon | 1 | $32 |
| Evofem Biosciences, Inc. | 1 | $20 |
| Ferring Pharmaceuticals Inc. | 1 | $17 |
| Duchesnay USA Incorporated | 1 | $16 |
| Therapeuticsmd, Inc. | 1 | $13 |
| Johnson & Johnson | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Orilissa$7,348
- ORIAHNN$1,050
- Da Vinci Surgical System$117
How this compares
$10,445 in reported general payments places this provider in the 95th percentile of 3,784 obstetrics & gynecology providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 60 | $4,425 |
| YuvafemEstradiol | 25 | $3,649 |
| ValacyclovirValacyclovir Hcl | 11 | $1,214 |
| Clobetasol Propionate | 11 | $562 |
| Nystatin | 13 | $137 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Chula Vista
- Steve YuNorthridge$964K
- Samir HageRedlands$640K
- Malcolm MunroLos Angeles$609K
- Michael KrychmanCosta Mesa$547K
- Anita NelsonTorrance$530K
- Jan SegnitzSan Jose$511K
- Risa KaganBerkeley$497K
- Michael GreenOxnard$424K
- Howard SalvaySanta Cruz$421K
- Marc WinterLaguna Hills$399K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.